Elevance Health (ELV) news
Recent news
Elevance Health - Announces 2027 Medicare Advantage plans
Elevance Health is finalizing its 2027 Medicare Advantage plans amid a shifting regulatory landscape influenced by recent legal developments. A federal court ruling in favor of Clover Health has prompted the Centers for Medicare & Medicaid Services (CMS) to recalculate quality ratings for certain…
AInvest Wire · Oct 1, 2026Elevance sees 3Q EPS tracking ahead of previous outlook: CFO
AInvest Wire · Sep 10, 2026Elevance still sees FY adj EPS at least $27.00, est. $27.16
Elevance Health, Inc. (NYSE: ELV) reported second quarter 2026 results on July 15, 2026, and reaffirmed its full-year 2026 adjusted earnings per share (EPS) guidance of at least $27.00. Based on the company’s performance and current estimates, analysts project full-year adjusted EPS to reach…
AInvest Wire · Sep 10, 2026Elevance Health - Reaffirms FY2026 benefit expense ratio guidance of 90.2% plus or minus 50 bps - SEC filing
AInvest Wire · Sep 10, 2026Elevance Health - Reaffirms FY2026 earnings guidance of at least $20.10 per diluted share - SEC filing
AInvest Wire · Sep 10, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.